These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2229464)

  • 1. Cognitive performance and mood in patients with chronic insomnia during 14-day use of flurazepam and midazolam.
    Judd LL; Ellinwood E; McAdams LA
    J Clin Psychopharmacol; 1990 Aug; 10(4 Suppl):56S-67S. PubMed ID: 2229464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychomotor performance in chronic insomniacs during 14-day use of flurazepam and midazolam.
    Moskowitz H; Linnoila M; Roehrs T
    J Clin Psychopharmacol; 1990 Aug; 10(4 Suppl):44S-55S. PubMed ID: 2229463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep evaluation in chronic insomniacs during 14-day use of flurazepam and midazolam.
    Kripke DF; Hauri P; Ancoli-Israel S; Roth T
    J Clin Psychopharmacol; 1990 Aug; 10(4 Suppl):32S-43S. PubMed ID: 2229462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug performance sensitivity: a pilot study.
    Moskowitz H; Chen D
    J Clin Psychopharmacol; 1990 Aug; 10(4 Suppl):20S-23S. PubMed ID: 2229458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of chronic insomniacs examined in a multicenter 14-day study of flurazepam and midazolam.
    Roth T; Roehrs T; Linnoila M; Judd LL
    J Clin Psychopharmacol; 1990 Aug; 10(4 Suppl):24S-27S. PubMed ID: 2229459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations of flurazepam and midazolam in chronic insomniacs during 14-day use and their relationship to therapeutic effects and next-day performance and mood.
    Ellinwood E; Linnoila M; Marsh G
    J Clin Psychopharmacol; 1990 Aug; 10(4 Suppl):68S-75S. PubMed ID: 2229465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter 14-day study of flurazepam and midazolam in chronic insomniacs: general discussion and conclusions.
    Johnson LC; Chernik DA; Hauri P
    J Clin Psychopharmacol; 1990 Aug; 10(4 Suppl):76S-90S. PubMed ID: 2229466
    [No Abstract]   [Full Text] [Related]  

  • 8. A multicenter study of sleep, performance, and plasma levels in chronic insomniacs during 14-day use of flurazepam and midazolam: executive summary.
    Chen D; Chernik DA; Ellinwood E; Hauri P; Johnson LC; Judd LL; Kripke DF; Linnoila M; Moskowitz H; Roth T
    J Clin Psychopharmacol; 1990 Aug; 10(4 Suppl):3S-4S. PubMed ID: 2229461
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative study on the effects of brotizolam and flurazepam on sleep and performance in the elderly.
    Mamelak M; Csima A; Buck L; Price V
    J Clin Psychopharmacol; 1989 Aug; 9(4):260-7. PubMed ID: 2671059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep, performance, and plasma levels in chronic insomniacs during 14-day use of flurazepam and midazolam: methodology.
    Chernik DA; Johnson LC; Kanitra L
    J Clin Psychopharmacol; 1990 Aug; 10(4 Suppl):10S-19S. PubMed ID: 2229457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep, performance, and plasma levels in chronic insomniacs during 14-day use of flurazepam and midazolam: an introduction.
    Johnson LC; Chernik DA; Sateia MJ
    J Clin Psychopharmacol; 1990 Aug; 10(4 Suppl):5S-9S. PubMed ID: 2121802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical safety of flurazepam and midazolam during 14-day use in chronic insomniacs.
    Sateia MJ; Hauri P; Kripke D; Roehrs T
    J Clin Psychopharmacol; 1990 Aug; 10(4 Suppl):28S-31S. PubMed ID: 2229460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Objective measurements of daytime sleepiness and performance comparing quazepam with flurazepam in two adult populations using the Multiple Sleep Latency Test.
    Dement WC
    J Clin Psychiatry; 1991 Sep; 52 Suppl():31-7. PubMed ID: 1680123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the efficacy, tolerance and residual effects of zopiclone, flurazepam and placebo in insomniac outpatients.
    Ponciano E; Freitas F; Camara J; Faria M; Barreto M; Hindmarch I
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():69-77. PubMed ID: 2201731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind evaluation of temazepam, flurazepam, and placebo in geriatric insomniacs.
    Fillingim JM
    Clin Ther; 1982; 4(5):369-80. PubMed ID: 6121625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.
    Erman M; Seiden D; Zammit G; Sainati S; Zhang J
    Sleep Med; 2006 Jan; 7(1):17-24. PubMed ID: 16309958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of flurazepam and midazolam on sleep and next-day performance in chronic insomniacs: report of a multicenter study.
    J Clin Psychopharmacol; 1990 Aug; 10(4 Suppl):1S-90S. PubMed ID: 2229456
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative study of lormetazepam and flurazepam in the treatment of insomnia.
    Melo de Paula AJ
    Clin Ther; 1984; 6(4):500-8. PubMed ID: 6380724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of zopiclone as compared to flurazepam on sleep in women over 40 years of age.
    Quadens OP; Hoffman G; Buytaert G
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():146-55. PubMed ID: 7188372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: study with intravenous midazolam.
    Chernik DA; Gillings D; Laine H; Hendler J; Silver JM; Davidson AB; Schwam EM; Siegel JL
    J Clin Psychopharmacol; 1990 Aug; 10(4):244-51. PubMed ID: 2286697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.